# Amgen Inc. (AMGN) — Q2-2014 Earnings Results

**Report date:** 2014-07-29 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q2-2014

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 0.54%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.37 | N/A | +19.28% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's current trajectory while remaining cautious about market conditions.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They emphasized ongoing investments in research and development.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Amgen's strong EPS performance indicates better-than-expected profitability, which likely contributed to the slight increase in stock price. However, the lack of revenue data and guidance may leave investors cautious. The stock's modest rise suggests that while investors are pleased with the earnings beat, they are also looking for more clarity on future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q2-2014_